ANTX Sale Disclosure
Readnour Robin Shane · SEC Form 4 · Filed Sep 11, 2026
Sale
Calculated transaction value
$3.15K
Readnour Robin Shane Director
ANTX
Transaction date
Sep 9, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 2 days later
ANTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 523 shares @ $6.02
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-389545
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$6.67K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| An2 Therapeutics, Inc. ANTX | Sale | Sep 9, 2026 | $3.52K |
| An2 Therapeutics, Inc. ANTX Current | Sale | Sep 9, 2026 | $3.15K |